Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Cash from Investing Activities (2022 - 2026)

Indivior Pharmaceuticals has reported Cash from Investing Activities over the past 5 years, most recently at -$19.0 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 280.0% year-over-year to -$19.0 million; the TTM value through Mar 2026 reached -$80.0 million, down 305.13%, while the annual FY2025 figure was -$66.0 million, 195.65% down from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$19.0 million at Indivior Pharmaceuticals, up from -$24.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $35.0 million in Q3 2024 and troughed at -$127.0 million in Q1 2023.
  • A 5-year average of -$11.4 million and a median of -$1.0 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 3600.0% in 2024 and later plummeted 1800.0% in 2025.
  • Year by year, Cash from Investing Activities stood at -$1.0 million in 2022, then skyrocketed by 1000.0% to $9.0 million in 2023, then dropped by 11.11% to $8.0 million in 2024, then tumbled by 400.0% to -$24.0 million in 2025, then increased by 20.83% to -$19.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for INDV at -$19.0 million in Q1 2026, -$24.0 million in Q4 2025, and -$20.0 million in Q3 2025.